To identify the most suitable cell line for the in vitro evaluation of the radiolabeled ligand, CCK-2R protein expression was investigated in human cancer cell lines derived from tumors of different origins (non-small cell lung cancer, skin cancer, prostate cancer, breast cancer, and colon cancer). This evidence concerns the gene CCKBR and prostate cancer.